Looking back at 2024 in the European Journal of Human Genetics.

Alisdair McNeill
Author Information
  1. Alisdair McNeill: Division of Neuroscience and Neuroscience Institute, The University of Sheffield, Sheffield, UK. a.mcneill@sheffield.ac.uk.

Abstract

No abstract text available.

References

  1. Tiller JM, Stott A, Finlay K, Boughtwood T, Madelli EO, Horton A, et al. Direct notification by health professionals of relatives at-risk of genetic conditions (with patient consent): views of the Australian public. Eur J Hum Genet. 2024;32:98���108. [DOI: 10.1038/s41431-023-01395-9]
  2. N����s C, von Salom�� J, Ros��n A. Patients��� perceptions and practices of informing relatives: a qualitative study within a randomised trial on healthcare-assisted risk disclosure. Eur J Hum Genet. 2024;32:448���55. [DOI: 10.1038/s41431-024-01544-8]
  3. ��fverholm A, Karlsson P, Ros��n A. The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. Eur J Hum Genet. 2024;32:539���44. [DOI: 10.1038/s41431-024-01551-9]
  4. Vears DF, Lynch F, Nisselle A, Ayres S, Stark Z. Rapid genomic testing in critically ill patients with genetic conditions: position statement by the Human Genetics Society of Australasia. Eur J Hum Genet. 2024;32:150���4. [DOI: 10.1038/s41431-023-01477-8]
  5. Prosenc B, Cizek Sajko M, Kavsek G, Herzog M, Peterlin B. Perception of genomic newborn screening among peripartum mothers. Eur J Hum Genet. 2024;32:163���70. [DOI: 10.1038/s41431-023-01497-4]
  6. Di Carlo C, Mighton C, Clausen M, Joshi E, Casalino S, Kim THM, et al. Parents��� attitudes towards research involving genome sequencing of their healthy children: a qualitative study. Eur J Hum Genet. 2024;32:171���5. [DOI: 10.1038/s41431-023-01476-9]
  7. Tiller J, Bakshi A, Dowling G, Keogh L, Mcinerney-Leo A, Barlow-Stewart K, et al. Community concerns about genetic discrimination in life insurance persist in Australia: A survey of consumers offered genetic testing. Eur J Hum Genet. 2024;32:286���94. [DOI: 10.1038/s41431-023-01373-1]
  8. van der Pol KH, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, et al. Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. Eur J Hum Genet. 2024;32:155���62. [DOI: 10.1038/s41431-022-01180-0]
  9. Beunk L, Nijenhuis M, Soree B, de Boer-Veger NJ, Buunk AM, Guchelaar HJ, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. Eur J Hum Genet. 2024;32:278���85. [DOI: 10.1038/s41431-023-01347-3]
  10. Massmann A, Christensen KD, Van Heukelom J, Schultz A, Shaukat MHS, Hajek C, et al. Clinical impact of preemptive pharmacogenomic testing on antiplatelet therapy in a real-world setting. Eur J Hum Genet. 2024;32:895���902. [DOI: 10.1038/s41431-024-01567-1]
  11. Ramzan M, Zafeer MF, Abad C, Guo S, Owrang D, Alper O, et al. Genetic heterogeneity in hereditary hearing loss: Potential role of kinociliary protein TOGARAM2. Eur J Hum Genet. 2024;32:639���46. [DOI: 10.1038/s41431-024-01562-6]
  12. Lu X, Ng K, Pinto E Vairo F, Collins J, Cohn R, et al. Novel protein-truncating variants of a chromatin-modifying gene MSL2 in syndromic neurodevelopmental disorders. Eur J Hum Genet. 2024;32:879���83. [DOI: 10.1038/s41431-024-01576-0]
  13. Uctepe E, Vona B, Esen FN, Sonmez FM, Smol T, T��mer S, et al. Bi-allelic truncating variants in CASP2 underlie a neurodevelopmental disorder with lissencephaly. Eur J Hum Genet. 2024;32:52���60. [DOI: 10.1038/s41431-023-01461-2]
  14. Yap P, Riley LG, Kakadia PM, Bohlander SK, Curran B, Rahimi MJ, et al. Biallelic ATP2B1 variants as a likely cause of a novel neurodevelopmental malformation syndrome with primary hypoparathyroidism. Eur J Hum Genet. 2024;32:125���9. [DOI: 10.1038/s41431-023-01484-9]
  15. Traverso M, Baratto S, Iacomino M, Di Duca M, Panicucci C, Casalini S, et al. DAG1 haploinsufficiency is associated with sporadic and familial isolated or pauci-symptomatic hyperCKemia. Eur J Hum Genet. 2024;32:342���9. [DOI: 10.1038/s41431-023-01516-4]
  16. Harms FL, Rexach JE, Efthymiou S, Aynekin B, Per H, G��le�� A, et al. Loss of TBC1D2B causes a progressive neurological disorder with gingival overgrowth. Eur J Hum Genet. 2024;32:558���66. [DOI: 10.1038/s41431-024-01563-5]
  17. Guleray Lafci N, van Goor M, Cetinkaya S, van der Wijst J, Acun M, Kurt Colak F, et al. Decreased calcium permeability caused by biallelic TRPV5 mutation leads to autosomal recessive renal calcium-wasting hypercalciuria. Eur J Hum Genet. 2024;32:1506���14. [DOI: 10.1038/s41431-024-01589-9]
  18. Nicolle R, Boutaud L, Loeuillet L, Talhi N, Grotto S, Bourgon N, et al. Expanding the phenotypic spectrum of LIG4 pathogenic variations: neuro-histopathological description of 4 fetuses with stenosis of the aqueduct. Eur J Hum Genet. 2024;32:545���9. [DOI: 10.1038/s41431-024-01558-2]
  19. Vanbelleghem E, Van Damme T, Beyens A, Symoens S, Claes K, De Backer J, et al. Myhre syndrome in adulthood: clinical variability and emerging genotype-phenotype correlations. Eur J Hum Genet. 2024;32:1086���94. [DOI: 10.1038/s41431-024-01664-1]
  20. Cascajo-Almenara MV, Juli��-Palacios N, Urreizti R, S��nchez-Cuesta A, Fern��ndez-Ayala DM, Garc��a-D��az E, et al. Mutations of GEMIN5 are associated with coenzyme Q10 deficiency: long-term follow-up after treatment. Eur J Hum Genet. 2024;32:426���34. [DOI: 10.1038/s41431-023-01526-2]
  21. Riley LG, Sabui S, Said HM, Niaz A, Girisha KM, Radhakrishnan P, et al. Genome sequencing enables diagnosis and treatment of SLC5A6 neuropathy. Eur J Hum Genet. 2024;32:947���53. [DOI: 10.1038/s41431-024-01641-8]
  22. Pettenuzzo I, Carli S, S��nchez-Cuesta A, Isidori F, Montanari F, Grippa M, et al. COQ7 defect causes prenatal onset of mitochondrial CoQ10 deficiency with cardiomyopathy and gastrointestinal obstruction. Eur J Hum Genet. 2024;32:938���46. [DOI: 10.1038/s41431-024-01615-w]
  23. Yoon JG, Lee S, Cho J, Kim N, Kim S, Kim MJ, et al. Diagnostic uplift through the implementation of short tandem repeat analysis using exome sequencing. Eur J Hum Genet. 2024;32:584���7. [DOI: 10.1038/s41431-024-01542-w]
  24. Bj��rnstad PM, Aal��kken R, ��sheim J, Sundaram AYM, Felde CN, ��stby GH, et al. A 39���kb structural variant causing Lynch Syndrome detected by optical genome mapping and nanopore sequencing. Eur J Hum Genet. 2024;32:513���20. [DOI: 10.1038/s41431-023-01494-7]
  25. Awamleh Z, Choufani S, Wu W, Rots D, Dingemans AJM, Nadif Kasri N, et al. A new blood DNA methylation signature for Koolen-de Vries syndrome: Classification of missense KANSL1 variants and comparison to fibroblast cells. Eur J Hum Genet. 2024;32:324���32. [DOI: 10.1038/s41431-024-01538-6]
  26. Husson T, Lecoquierre F, Nicolas G, Richard AC, Afenjar A, Audebert-Bellanger S, et al. Episignatures in practice: independent evaluation of published episignatures for the molecular diagnostics of ten neurodevelopmental disorders. Eur J Hum Genet. 2024;32:190���9. [DOI: 10.1038/s41431-023-01474-x]
  27. Pankratov V, Mezzavilla M, Aneli S, Kuznetsov IA, Fusco D, Wilson JF, et al. Ancestral genetic components are consistently associated with the complex trait landscape in European biobanks. Eur J Hum Genet. 2024;32:1492���9. [DOI: 10.1038/s41431-024-01678-9]
  28. Schobers G, Pennings M, de Vries J, Brouwer-Brolsma E, Cremers S, Faessen JPM, et al. Uncovering recessive alleles in rare Mendelian disorders by genome sequencing of 174 individuals with monoallelic pathogenic variants. Eur J Hum Genet. 2025;33:56���64. [DOI: 10.1038/s41431-024-01694-9]
  29. Nakano Y, Acker M, Druker H, van Engelen K, Meyn MS, Wasserman JD, et al. Late-onset tumors in rhabdoid tumor predisposition syndrome type-1 (RTPS1) and implications for surveillance. Eur J Hum Genet. 2024;32:1474���82. [DOI: 10.1038/s41431-024-01674-z]
  30. Elfatih A, Saad C, Qatar Genome Program Research Consortium, Mifsud B, Mbarek H. Analysis of 14,392 whole genomes reveals 3.5% of Qataris carry medically actionable variants. Eur J Hum Genet. 2024;32:1465���73. [DOI: 10.1038/s41431-024-01656-1]
  31. McDevitt T, Durkie M, Arnold N, Burghel GJ, Butler S, Claes KBM, et al. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer. Eur J Hum Genet. 2024;32:479���88. [DOI: 10.1038/s41431-023-01507-5]
  32. Mishra RK, Singh PP, Rai N, Desai S, Pandey P, Tiwary SK et al. Reconstructing the population history of the Nicobarese. Eur J Hum Genet. 2024. https://doi.org/10.1038/s41431-024-01720-w .

Word Cloud

Created with Highcharts 10.0.0Lookingback2024EuropeanJournalHumanGenetics

Similar Articles

Cited By

No available data.